ERBB2 and breast cancer: And TOM1L1 was able to promote ERBB2-induced breast cancer cell invasion by driving membrane delivery of membrane-type 1 matrix metalloprotease (MT1-MMP) (Chevalier et al., 2016a; Chevalier et al., 2016b).